It canbut skincare cant replace fat loss
oral formulation (Rybelsus) also available Lixisenatide (Lyxumia) once-daily injection NICE guidance for type 2 diabetes (NG28) recommends GLP-1 receptor agonists in specific circumstances: typically as a third-line option when other treatments haven't achieved adequate glycaemic control, particularly in people with a BMI 35 kg/m (adjusted for ethnicity), or for whom weight loss would benefit other obesity-related comorbidities, or for whom insulin would have significant occupational implications
Its less reassuring than a refund, but probably more useful in the long term
The medication has been approved for weight management in individuals having a body mass index (BMI) equal to or exceeding 30 or a body mass index of 27 or above who possess at least one condition related to weight, like type 2 diabetes or elevated blood pressure
Gentle, natural cleansers support a healthier scalp environment for regrowth
Vidal, J., Flores, L., Jimnez, A., Pan, A